Valuation: Teva Pharmaceutical Industries Limited

Market Cap 50.45B 45.47B 42.01B 37.98B 71.85B 4,732B 73.63B 503B 201B 2,534B 189B 185B 8,065B P/E 2026 *
129x
P/E 2027 * 23.5x
Enterprise Value 62.42B 56.26B 51.98B 46.99B 88.9B 5,855B 91.1B 623B 248B 3,136B 234B 229B 9,979B EV / Sales 2026 *
3.72x
EV / Sales 2027 * 3.39x
Free-Float
91.17%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Limited

Manager TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 53 2019-12-21
Chief Operating Officer 52 2024-06-02
Director TitleAgeSince
Director/Board Member 70 2008-12-31
Chairman 78 2017-02-05
Director/Board Member 65 2015-08-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/5/26 Sell

Director

-17 0.0000%
8/3/26 Exercice

Chief Technology Officer

131,066 0.0112%
8/3/26 Exercice

Head of Human Resources

38,481 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+2.01% - - 50.45B
+0.35%+1.36%+45.38%+140.47% 1,280B
-0.13%+1.48%+44.67%+90.43% 675B
+0.37%+0.05%+31.00%+112.84% 521B
+0.02%+1.52%+39.21%+69.76% 386B
-0.59%-2.11%+61.83%+45.16% 363B
-1.29%-1.13%+27.54%+58.29% 301B
+0.09%-0.91%+3.19%+37.72% 286B
+0.62%-2.17%+38.31%+75.12% 253B
-0.67%-2.72%+38.49%+123.56% 211B
Average +0.24%-0.51%+36.62%+83.71% 475B
Weighted average by Cap. +0.49%+0.20%+39.52%+97.37%

Financials

2026 *2027 *
Net sales 16.78B 15.12B 13.97B 12.63B 23.89B 1,574B 24.48B 167B 66.73B 843B 62.97B 61.63B 2,682B 17.35B 15.64B 14.45B 13.06B 24.71B 1,627B 25.32B 173B 69.01B 872B 65.12B 63.73B 2,774B
Net income 689M 621M 574M 519M 982M 64.66B 1.01B 6.88B 2.74B 34.63B 2.59B 2.53B 110B 2.4B 2.17B 2B 1.81B 3.42B 225B 3.51B 23.97B 9.56B 121B 9.02B 8.82B 384B
Net Debt 11.97B 10.79B 9.97B 9.01B 17.05B 1,123B 17.47B 119B 47.61B 601B 44.93B 43.97B 1,914B 8.36B 7.54B 6.96B 6.3B 11.91B 784B 12.21B 83.47B 33.27B 420B 31.39B 30.72B 1,337B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Teva Pharmaceutical Industries Limited